MICHELLE ESCUE: Open Payments
NPI 1528308715 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,322 in 97 payments from 11 companies in 2025. Trend: 2023 $3,421 · 2024 $3,002 · 2025 $2,322
Food & beverage: $2,322
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 29 | $985 |
| PROTEGA PHARMACEUTIALS INC | 27 | $474 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $202 |
| Collegium Pharmaceutical, Inc. | 11 | $194 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $164 |
| PFIZER INC. | 5 | $93 |
| Averitas Pharma Inc. | 3 | $71 |
| SI-BONE, INC. | 2 | $54 |
| Valinor Pharma, LLC | 2 | $35 |
| Boston Scientific Corporation | 1 | $31 |
Products named: PROCLAIM, ROXYBOND, ETERNA, RELISTOR, JOURNAVX, Belbuca, NURTEC ODT, XTAMPZA.
Industry payments across TX — which companies pay providers there.
